These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23942871)

  • 1. The effect of alendronate on the expression of important cell factors in osteoclasts.
    Zhang Q; Liu M; Zhou Y; Liu W; Shen J; Shen Y; Liu L
    Mol Med Rep; 2013 Oct; 8(4):1195-203. PubMed ID: 23942871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of rotative stress on CAII, FAS, FASL, OSCAR, and TRAP gene expression in osteoclasts.
    Qing Hong Z; Meng Tao L; Yi Z; Wei L; Ju Xiang S; Li L
    J Cell Biochem; 2013 Feb; 114(2):388-97. PubMed ID: 22949349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats.
    Bradaschia-Correa V; Moreira MM; Arana-Chavez VE
    Cell Tissue Res; 2013 Jul; 353(1):79-86. PubMed ID: 23636419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo.
    Yoshimatsu M; Kitaura H; Fujimura Y; Eguchi T; Kohara H; Morita Y; Yoshida N
    Bone; 2009 Nov; 45(5):1010-6. PubMed ID: 19651258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors.
    Hedvičáková V; Žižková R; Buzgo M; Rampichová M; Filová E
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33809737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model.
    Komatsu K; Shimada A; Shibata T; Wada S; Ideno H; Nakashima K; Amizuka N; Noda M; Nifuji A
    J Endocrinol; 2013 Nov; 219(2):145-58. PubMed ID: 24096963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin influences the bone resorption activity of osteoclasts.
    Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP
    Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
    Shu G; Yamamoto K; Nagashima M
    Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alendronate on osteoclast formation and activity in vitro.
    Martins CA; Leyhausen G; Volk J; Geurtsen W
    J Endod; 2015 Jan; 41(1):45-9. PubMed ID: 25442070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
    Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
    Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local delivery of alendronate eluting chitosan scaffold can effectively increase osteoblast functions and inhibit osteoclast differentiation.
    Kim SE; Suh DH; Yun YP; Lee JY; Park K; Chung JY; Lee DW
    J Mater Sci Mater Med; 2012 Nov; 23(11):2739-49. PubMed ID: 22850978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
    Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
    Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale.
    Pasqualetti S; Congiu T; Banfi G; Mariotti M
    Int J Exp Pathol; 2015 Feb; 96(1):11-20. PubMed ID: 25603732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
    Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
    J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silicate modulates the cross-talk between osteoblasts (SaOS-2) and osteoclasts (RAW 264.7 cells): inhibition of osteoclast growth and differentiation.
    Schröder HC; Wang XH; Wiens M; Diehl-Seifert B; Kropf K; Schloßmacher U; Müller WE
    J Cell Biochem; 2012 Oct; 113(10):3197-206. PubMed ID: 22615001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation.
    Vanhara P; Lincová E; Kozubík A; Jurdic P; Soucek K; Smarda J
    Differentiation; 2009 Nov; 78(4):213-22. PubMed ID: 19695766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
    Chen T; Knapp AC; Wu Y; Huang J; Lynch JS; Dickson JK; Lawrence RM; Feyen JH; Agler ML
    Assay Drug Dev Technol; 2006 Aug; 4(4):387-96. PubMed ID: 16945012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant osteoclast formation and long-term oral bisphosphonate therapy.
    Weinstein RS; Roberson PK; Manolagas SC
    N Engl J Med; 2009 Jan; 360(1):53-62. PubMed ID: 19118304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.